269 related articles for article (PubMed ID: 8797862)
1. Cyclin gene amplification and overexpression in breast and ovarian cancers: evidence for the selection of cyclin D1 in breast and cyclin E in ovarian tumors.
Courjal F; Louason G; Speiser P; Katsaros D; Zeillinger R; Theillet C
Int J Cancer; 1996 Aug; 69(4):247-53. PubMed ID: 8797862
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of cyclin D1 in epithelial ovarian cancers.
Worsley SD; Ponder BA; Davies BR
Gynecol Oncol; 1997 Feb; 64(2):189-95. PubMed ID: 9038263
[TBL] [Abstract][Full Text] [Related]
3. PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas.
Jares P; Fernández PL; Campo E; Nadal A; Bosch F; Aiza G; Nayach I; Traserra J; Cardesa A
Cancer Res; 1994 Sep; 54(17):4813-7. PubMed ID: 8062283
[TBL] [Abstract][Full Text] [Related]
4. Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma.
Zhang YJ; Jiang W; Chen CJ; Lee CS; Kahn SM; Santella RM; Weinstein IB
Biochem Biophys Res Commun; 1993 Oct; 196(2):1010-6. PubMed ID: 8240318
[TBL] [Abstract][Full Text] [Related]
5. Cyclin D1 (PRAD1) protein expression in breast cancer: approximately one-third of infiltrating mammary carcinomas show overexpression of the cyclin D1 oncogene.
Zukerberg LR; Yang WI; Gadd M; Thor AD; Koerner FC; Schmidt EV; Arnold A
Mod Pathol; 1995 Jun; 8(5):560-7. PubMed ID: 7675778
[TBL] [Abstract][Full Text] [Related]
6. A truncated cyclin D1 gene encodes a stable mRNA in a human breast cancer cell line.
Lebwohl DE; Muise-Helmericks R; Sepp-Lorenzino L; Serve S; Timaul M; Bol R; Borgen P; Rosen N
Oncogene; 1994 Jul; 9(7):1925-9. PubMed ID: 8208539
[TBL] [Abstract][Full Text] [Related]
7. Expression of molecular biomarkers in primary breast tumors implanted into a surrogate host: increased levels of cyclins correlate with tumor progression.
Wani G; Noyes I; Milo GE; D'Ambrosio SM
Mol Med; 1997 Apr; 3(4):273-83. PubMed ID: 9131589
[TBL] [Abstract][Full Text] [Related]
8. Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas.
Bellacosa A; de Feo D; Godwin AK; Bell DW; Cheng JQ; Altomare DA; Wan M; Dubeau L; Scambia G; Masciullo V; Ferrandina G; Benedetti Panici P; Mancuso S; Neri G; Testa JR
Int J Cancer; 1995 Aug; 64(4):280-5. PubMed ID: 7657393
[TBL] [Abstract][Full Text] [Related]
9. Expression and amplification of cyclin genes in human breast cancer.
Buckley MF; Sweeney KJ; Hamilton JA; Sini RL; Manning DL; Nicholson RI; deFazio A; Watts CK; Musgrove EA; Sutherland RL
Oncogene; 1993 Aug; 8(8):2127-33. PubMed ID: 8336939
[TBL] [Abstract][Full Text] [Related]
10. Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining.
Gillett C; Fantl V; Smith R; Fisher C; Bartek J; Dickson C; Barnes D; Peters G
Cancer Res; 1994 Apr; 54(7):1812-7. PubMed ID: 8137296
[TBL] [Abstract][Full Text] [Related]
11. [Invasive ductal carcinoma of the breast: study of the number of copies of the CCND1 gene and chromosome 11 using fluorescence in situ hybridization (FISH) in comparison with expression of cyclin D1 protein and estrogen receptors (ER alpha) with immunohistochemical detection].
Mrhalová M; Kodet R; Strnad P
Cas Lek Cesk; 2002 Nov; 141(22):708-14. PubMed ID: 12532908
[TBL] [Abstract][Full Text] [Related]
12. Cyclin DI amplification is not associated with reduced overall survival in primary breast cancer but may predict early relapse in patients with features of good prognosis.
Seshadri R; Lee CS; Hui R; McCaul K; Horsfall DJ; Sutherland RL
Clin Cancer Res; 1996 Jul; 2(7):1177-84. PubMed ID: 9816285
[TBL] [Abstract][Full Text] [Related]
13. Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma.
Nishida N; Fukuda Y; Komeda T; Kita R; Sando T; Furukawa M; Amenomori M; Shibagaki I; Nakao K; Ikenaga M
Cancer Res; 1994 Jun; 54(12):3107-10. PubMed ID: 8205525
[TBL] [Abstract][Full Text] [Related]
14. Human cyclin D1 oncogene and esophageal squamous cell carcinoma.
Nakagawa H; Zukerberg L; Togawa K; Meltzer SJ; Nishihara T; Rustgi AK
Cancer; 1995 Aug; 76(4):541-9. PubMed ID: 8625145
[TBL] [Abstract][Full Text] [Related]
15. Homozygous deletion frequency and expression levels of the CDKN2 gene in human sarcomas--relationship to amplification and mRNA levels of CDK4 and CCND1.
Maelandsmo GM; Berner JM; Flørenes VA; Forus A; Hovig E; Fodstad O; Myklebost O
Br J Cancer; 1995 Aug; 72(2):393-8. PubMed ID: 7640224
[TBL] [Abstract][Full Text] [Related]
16. Expression of retinoblastoma gene product (pRb) in mantle cell lymphomas. Correlation with cyclin D1 (PRAD1/CCND1) mRNA levels and proliferative activity.
Jares P; Campo E; Pinyol M; Bosch F; Miquel R; Fernandez PL; Sanchez-Beato M; Soler F; Perez-Losada A; Nayach I; Mallofré C; Piris MA; Montserrat E; Cardesa A
Am J Pathol; 1996 May; 148(5):1591-600. PubMed ID: 8623927
[TBL] [Abstract][Full Text] [Related]
17. MYEOV: a candidate gene for DNA amplification events occurring centromeric to CCND1 in breast cancer.
Janssen JW; Cuny M; Orsetti B; Rodriguez C; Vallés H; Bartram CR; Schuuring E; Theillet C
Int J Cancer; 2002 Dec; 102(6):608-14. PubMed ID: 12448002
[TBL] [Abstract][Full Text] [Related]
18. Expression of cyclin D1 and EMS1 in bladder tumours; relationship with chromosome 11q13 amplification.
Bringuier PP; Tamimi Y; Schuuring E; Schalken J
Oncogene; 1996 Apr; 12(8):1747-53. PubMed ID: 8622895
[TBL] [Abstract][Full Text] [Related]
19. Frequent overexpression of the cyclin D1 oncogene in invasive lobular carcinoma of the breast.
Oyama T; Kashiwabara K; Yoshimoto K; Arnold A; Koerner F
Cancer Res; 1998 Jul; 58(13):2876-80. PubMed ID: 9661905
[TBL] [Abstract][Full Text] [Related]
20. Expression of cyclin Ds in relation to p53 status in human breast carcinomas.
Bukholm IK; Berner JM; Nesland JM; Børresen-Dale AL
Virchows Arch; 1998 Sep; 433(3):223-8. PubMed ID: 9769125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
